Mr Steve Lehrer

Steven Lehrer is a Board and Senior Management Advisor to Life Science Companies. Steve has over 30 years of experience starting, growing and running life science based businesses focused on commercializing new technology. Steve has extensive experience in pharmaceutical R&D, regulatory and operations, biopharmaceutical R&D, regulatory, operations, commercialization and biosimilars, molecular diagnostics discovery, validation and commercialization, bioinformatics/health care econometrics analysis, health care reimbursement/establishing reimbursement for new medical technology and synthetic biology development and commercialization.

Steve was CEO of Cipla BioTec, which demonstrated the ability to develop affordable cancer biosimilars including negotiating various government incentive packages worldwide to build biopharmaceutical development and manufacturing facilities. Prior to joining Cipla BioTec, Steve was an EVP Consulting Services at Optimal Strategix Group, EVP of Commercial Operations and CEO of Asia for Adamas Pharmaceuticals, CEO of Geneos, President of Glycominds, CEO of DNA Sciences and a Division President at Monsanto. Prior to his career at Monsanto, Steve worked for McKinsey & Co. and P&G.

Steve currently sits on the Board of Directors of 2 life science companies and provides strategy advice to several CEO/senior management teams on a wide range of topics from commercial strategy through operations / business development and portfolio planning.

Steve has a Master's Degree from The Graduate School of Business at Harvard University and a BSE in Chemical Engineering and a BA in Economics from the University of Maryland, College Park.